Nasdaq Welcomes Entellus Medical, Inc. (Nasdaq: ENTL) to The Nasdaq Stock Market
Entellus Medical is a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room. The company is based in
"Entellus Medical is dedicated to providing new innovative treatment for patients who need sinus relief," said
By listing with Nasdaq, Entellus Medical joins some of the world's largest and most revolutionary healthcare companies. Nasdaq is the exchange of choice to 77 percent of healthcare companies listed in the U.S. Markets.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,400 listed companies with a market value of over
NDAQG
MEDIA RELATIONS CONTACT:Source: The NASDAQ OMX Group, Inc.Will Briganti (646) 441-5012 william.briganti@nasdaq.comChristine Barna (646) 441-5310 Christine.Barna@nasdaq.com
News Provided by Acquire Media
